Advisory Board — Medscape Cardiology
Board Members
- Henry R. Black, MD
- Clinical Professor of Internal Medicine
Director of Hypertension Research
New York University Medical Center
New York, New York
- Clinical Professor of Internal Medicine
- Timothy Gardner, MD
- Professor, Department of Surgery
Stanley Kimmel Medical College
Thomas Jefferson University
Philadelphia, Pennsylvania
Medical Director
Center for Heart and Vascular Health
Christiana Care Health System
Newark, Delaware
- Professor, Department of Surgery
- Samuel Z. Goldhaber, MD
- Professor of Medicine
Harvard Medical School
Section Head
Vascular Medicine
Director
Thrombosis Research Group
Brigham and Women’s Hospital
Boston, Massachussets
- Professor of Medicine
- Robert Harrington, MD
- Arthur L. Bloomfield Professor of Medicine
Chair, Department of Medicine
Stanford University
Stanford, California
- Arthur L. Bloomfield Professor of Medicine
- John M. Mandrola, MD
- Clinical Electrophysiologist
Baptist Medical Associates
Louisville, Kentucky
- Clinical Electrophysiologist
- Roxana Mehran, MD
- Professor of Medicine (Cardiology) and Population Health Science and Policy
Director
Interventional Cardiovascular Research and Clinical Trials
Icahn School of Medicine at Mount Sinai
New York, New York
- Professor of Medicine (Cardiology) and Population Health Science and Policy
- Michelle L. O’Donoghue, MD, MPH
- TIMI Study Group
Harvard Medical School
Brigham and Women’s Hospital
Boston, Massachusetts
- TIMI Study Group
- Ileana L. Piña, MD, MPH
- Professor of Medicine
Department of Cardiology
Professor of Epidemiology and Population Health
Associate Chief for Academic Affairs
Albert Einstein College of Medicine
Director of Cardiology
Montefiore Medical Center
Bronx, New York
- Professor of Medicine
- Melissa Walton-Shirley, MD
- Clinical Cardiologist
Cardiology Associates
Glasgow, Kentucky
- Clinical Cardiologist
- Howard S. Weintraub, MD
- Clinical Associate Professor of Medicine and Cardiology
New York University School of Medicine
Clinical Director, NYU Center for the Prevention of Cardiovascular Disease
NYU-Langone Medical Center
New York, New York
- Clinical Associate Professor of Medicine and Cardiology
Board Member Details
Henry R. Black, MD
Adjunct Professor of Medicine, New York University, New York, New York
Henry R. Black, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Zumbro; Pfizer Inc; Hospira
Received income in an amount equal to or greater than $250 from: Zumbro; Pfizer Inc; Hospira
Timothy Gardner, MD
Professor, Department of Surgery, Stanley Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania; Medical Director, Center for Heart and Vascular Health, Christiana Care Health System, Newark, Delaware
Timothy Gardner, MD, has disclosed no relevant financial relationships.
Samuel Z. Goldhaber, MD
Professor of Medicine, Harvard Medical School; Section Head, Vascular Medicine; Director, Thrombosis Research Group, Brigham and Women’s Hospital, Boston, Massachusetts
Samuel Z. Goldhaber, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Agile Therapeutics Inc.; Bayer HealthCare Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Portola Pharmaceuticals, Inc.; Zafgen
Received research grant from: Bio2 Medical Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; BTG EKOS; Daiichi Sankyo, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Robert Harrington, MD
Professor and Chair, Department of Medicine, Stanford University, Stanford, California
Robert A. Harrington, MD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: HCA Management Services; Medscape; MyoKardia, Inc.; Gilead Sciences, Inc.; The Medicines Company; Intermountain Health; Adverse Events; Amgen Inc; Element Science; Merck & Co., Inc; Vida Health; American Heart Association; Scanadu (mobile health); SignalPath (data)
Received research grants from: National Heart Lung and Blood Institute; Patient-Centered Outcomes Research Institute; Duke University; Harvard University; AstraZeneca Pharmaceuticals LP; CSL Behring; GlaxoSmithKline; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Merck & Co., Inc; Portola Pharmaceuticals, Inc.; Regado Biosciences; sanofi-aventis; The Medicines Company
Received income in an amount equal to or greater than $250 from: HCA Management Services; Medscape; MyoKardia, Inc.; Gilead Sciences, Inc.; The Medicines Company; Intermountain Health; Amgen Inc; Merck & Co., Inc; SignalPath (data)
John M. Mandrola, MD
Clinical Electrophysiologist, Baptist Medical Associates, Louisville, Kentucky
John M. Mandrola, MD, has disclosed no relevant financial relationships.
Roxana Mehran, MD
Professor of Medicine (Cardiology) and Population Health Science and Policy, Director, Interventional Cardiovascular Research and Clinical Trials, Icahn School of Medicine at Mount Sinai, New York, New York
Roxana Mehran, MD, has disclosed the following financial relationships:
Serve(d) as consultant to: Boston Scientific; Cardiovascular Systems, Inc.; Medscape, LLC; Shanghai BraccoSine Pharmaceutical Corp. Ltd.
Serve(d) on the advisory board for: Bristol-Myers Squibb Company (funding to institution)
Institution received consulting fees from: Abbott Laboratories; American College of Cardiology; CardioKinetix Inc.; Cardiovascular Research Foundation; The Spectranetics Corporation
Serve(d) as a speaker or member of a speakers bureau for: European Society of Cardiology; Gaffney Events Education; International Society for Cardiovascular Translational Research; Life Sciences Conferences; Northwestern University; Prime Healthcare Services; Promedica International CME; The Society of Thoracic Surgeons; University of Utah
Serve(d) on executive committee for: Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Osprey Medical
Institution received research funding from: AstraZeneca Pharmaceuticals LP; Bayer HealthCare Pharmaceuticals; Beth Israel Deaconess Medical Center; Bristol-Myers Squibb Company; CSL Behring; Eli Lilly and Company; Daiichi Sankyo, Inc.; Medtronic, Inc.; Novartis Pharmaceuticals Corporation; OrbusNeich
Has <1% equity interest in: Claret Medical, Inc.; Elixir Medical Corporation
Served as a medical monitor for: Claret Medical, Inc. (paid to institution)
Served as a member of the Data and Safety Monitoring Board for: Watermark Research Partners (paid to institution)
Spouse served as a consultant to: ABIOMED; The Medicines Company
Michelle L. O’Donoghue, MD, MPH
Investigator, TIMI Study Group; Assistant Professor of Medicine, Harvard Medical School; Associate Physician, Brigham and Women’s Hospital, Boston, Massachusetts
Michelle L. O'Donoghue, MD, MPH, has disclosed the following relevant financial relationships:
Received research grant from: Merck & Co., Inc.; GlaxoSmithKline; Eisai Inc.; AstraZeneca Pharmaceuticals LP; Janssen Pharmaceuticals
Ileana L. Piña, MD, MPH
Professor of Medicine, Department of Cardiology; Professor of Epidemiology and Population Health; Associate Chief for Academic Affairs, Albert Einstein College of Medicine; Director of Cardiology, Montefiore Medical Center, Bronx, New York
Ileana L. Piña, MD, MPH, has disclosed the following relevant financial relationships:
Serve(d) as a director, office, partner, employee, advisor, consultant, or trustee for: US Food and Drug Administration; Center for Devices and Radiological Health
Melissa Walton-Shirley, MD
Cardiologist, Cardiology Associates, Glasgow, Kentucky; St. Thomas Heart, Gallatin, Tennessee
Melissa K. Walton-Shirley, MD, has disclosed no relevant financial relationships.
Howard S. Weintraub, MD
Clinical Professor of Medicine/Cardiology, New York University School of Medicine; Clinical Director, New York University Center for the Prevention of Cardiovascular Disease, New York University Langone Medical Center, New York, New York
Howard S. Weintraub, MD, has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: Amgen Inc.; Gilead Sciences, Inc.
Received research grant from: Amarin Corporation plc; sanofi-aventis
Received income in an amount equal to or greater than $250 from: Amgen Inc.; Gilead Sciences, Inc.; Amarin Corporation plc; sanofi-aventis